Evoke plc (LON:EVOK – Get Free Report) dropped 10% during mid-day trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during mid-day trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on the company. Jefferies Financial Group reiterated a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a research note on Monday, December 16th. Berenberg Bank cut their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a research note on Wednesday, December 4th.
Check Out Our Latest Stock Report on EVOK
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Buying and Selling
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Corporate insiders own 27.00% of the company’s stock.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- What is a support level?
- MarketBeat Week in Review – 03/24 – 03/28
- What is the Nasdaq? Complete Overview with History
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- How to Calculate Stock Profit
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.